Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Completed Phase 1 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0028768 (Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00049283Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerTreatment